SCHEMBL1634724

SCHEMBL1634724

NS(=O)(=O)c1ccc(Nc2ncc3ccc(Oc4ccccc4)cc3n2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 7/20 0.62
CA1 P00915 6/20 0.59
CA2 P00918 6/20 0.59
CA9 Q16790 6/20 0.59
SOS1 Q07889 1/20 0.51
CA12 O43570 4/20 0.50
BRAF P15056 1/20 0.50
DKK1 O94907 1/20 0.50
GSK3B P49841 1/20 0.50
CA4 P22748 1/20 0.46
CDK2 P24941 2/20 0.46
CCNT1 O60563 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
CDK7 P50613 1/20 0.46
CDK9 P50750 1/20 0.46
CCNH P51946 1/20 0.46
GLO1 Q04760 1/20 0.45
AURKA O14965 1/20 0.45
AURKB Q96GD4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633690 0.89 IKBKB (0.57) IKBKBCA1CA2CA9CA12
SCHEMBL1632888 0.85 IKBKB (0.50) IKBKBCA1CA2CA9CA12
SCHEMBL1633099 0.85 IKBKB (0.65) IKBKBCA1CA2CA9CA12
SCHEMBL1571219 0.83 IKBKB (0.48) IKBKBCA1CA2CA9CA12
SCHEMBL27780313 0.81 IKBKB (0.50) IKBKBCA1CA2CA9CA12
SCHEMBL1634576 0.81 IKBKB (0.58) IKBKBCA1CA2CA9CA12
SCHEMBL1634963 0.80 BRAF (0.67) BRAF
SCHEMBL1633261 0.80 IKBKB (0.55) IKBKBCA1CA2CA9CA12
SCHEMBL1633423 0.79 IKBKB (0.63) IKBKBCA1CA2CA9CA12
SCHEMBL1631544 0.79 CDK1 (0.51) IKBKBCA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed